Flipping the paradigm on malaria transmission-blocking vaccines.
about
An antibody against an Anopheles albimanus midgut myosin reduces Plasmodium berghei oocyst developmentVampire bats and rabies: toward an ecological solution to a public health problemHeritable strategies for controlling insect vectors of diseasePlatform for Plasmodium vivax vaccine discovery and developmentArbovirosis and potential transmission blocking vaccinesGenome Investigations of Vector Competence in Aedes aegypti to Inform Novel Arbovirus Disease Control ApproachesThe Plasmodium bottleneck: malaria parasite losses in the mosquito vectorTranscriptome of the adult female malaria mosquito vector Anopheles albimanus.Immunization against a merozoite sheddase promotes multiple invasion of red blood cells and attenuates Plasmodium infection in mice.Differential roles of an Anopheline midgut GPI-anchored protein in mediating Plasmodium falciparum and Plasmodium vivax ookinete invasion.Comparative susceptibility of different biological forms of Anopheles stephensi to Plasmodium berghei ANKA strain.Decoding the ubiquitin-mediated pathway of arthropod disease vectors.Synergistic and antagonistic interactions between bednets and vaccines in the control of malaria.A role for heparan sulfate proteoglycans in Plasmodium falciparum sporozoite invasion of anopheline mosquito salivary glandsOokinete-interacting proteins on the microvillar surface are partitioned into detergent resistant membranes of Anopheles gambiae midgutsMosquito ingestion of antibodies against mosquito midgut microbiota improves conversion of ookinetes to oocysts for Plasmodium falciparum, but not P. yoeliiExpression, immunogenicity, histopathology, and potency of a mosquito-based malaria transmission-blocking recombinant vaccine.Approaching the target: the path towards an effective malaria vaccine.The Anopheles-midgut APN1 structure reveals a new malaria transmission-blocking vaccine epitopeLeishmania development in sand flies: parasite-vector interactions overview.A bioinformatics approach for integrated transcriptomic and proteomic comparative analyses of model and non-sequenced anopheline vectors of human malaria parasites.The effects of ingested mammalian blood factors on vector arthropod immunity and physiologyLimited sequence polymorphisms of four transmission-blocking vaccine candidate antigens in Plasmodium vivax Korean isolatesPlasmodium-Mosquito Interactions: A Tale of Roadblocks and Detours.Single-dose microparticle delivery of a malaria transmission-blocking vaccine elicits a long-lasting functional antibody response.No evidence for positive selection at two potential targets for malaria transmission-blocking vaccines in Anopheles gambiae s.s.Antibodies to a single, conserved epitope in Anopheles APN1 inhibit universal transmission of Plasmodium falciparum and Plasmodium vivax malaria.Transmission blocking vaccines to control insect-borne diseases: a review.Immune-mediated pathology of nematode infection in sheep--is immunity beneficial to the animal?Cell biology and immunology of malaria.The fibrinogen-like domain of FREP1 protein is a broad-spectrum malaria transmission-blocking vaccine antigen.Reduction of Mosquito Survival in Mice Vaccinated with Anopheles stephensi Glucose Transporter.M1 aminopeptidases as drug targets: broad applications or therapeutic niche?Vaccines: The take-home lesson.Ferroquine, an ingenious antimalarial drug: thoughts on the mechanism of action.Prevention and Control Strategies to Counter Zika Virus, a Special Focus on Intervention Approaches against Vector Mosquitoes-Current Updates.Asymptomatic Plasmodium vivax parasitaemia in the low-transmission setting: the role for a population-based transmission-blocking vaccine for malaria elimination.
P2860
Q26315471-35D01B3C-BDF7-4ED6-B079-9BF0C5872BA5Q26865217-C488914C-2ED4-4A43-86DD-6DE378101046Q26866094-F69F6C41-8505-484C-BAC9-CB664ED39286Q27021891-725A22D4-6D52-43EC-825B-9F917160C024Q27468657-8D822339-5774-4E96-8B7B-EE992854F743Q27787796-1B22DADE-64A5-4A9D-B03D-AB6D97FA87B5Q34142771-50B9B21D-8CE5-43D9-8ABB-34A8470F36A7Q34286214-B7CB48EC-709E-40CE-B255-777F145847A2Q34591062-63E7375C-E9A4-4635-98FA-256F8F83AF56Q34642131-0BF88A07-8C61-4BE8-B1D1-F19622B7CAC7Q35005612-966DC3B8-E453-498E-A28C-810CA2F93D11Q35036003-4BBE06E5-DB7F-4561-93C2-AD1A2A57F00CQ35189926-B9B149B0-EAF8-4A7D-900D-4374E4A767D7Q35215139-5E716745-0610-4FD2-903B-B818BACD16D3Q35526306-8BEF8FFA-F5B6-4150-8095-4AA2E2D1E3AFQ35532141-8F857FD2-68F1-43D8-BC9E-918FF4B64E66Q35867612-D5064734-F8A6-4391-9539-9689B4D6B16AQ35924716-650BBC4D-F101-4CFA-897C-D272A78E1F6AQ35989209-441367E6-436B-4D11-A8F4-4BD617EDE911Q36499194-C713A8CA-2CB0-4F00-A342-0F010A2E05D4Q36508101-7FD1049D-EBB6-4AEE-AA94-6C10F7D7E834Q36698998-D5F10419-112E-4FBC-AC02-63517734A42FQ36846823-AF60DB66-3CD7-4641-86EC-67129D11BD29Q36882568-2F893CA0-7945-4709-9016-E727677CE674Q36998403-B793995C-6748-48E2-A5D1-6292B83AB878Q37149175-1D824B6A-2D55-494A-8A85-CD4FC4C78A6BQ37546481-130F37B7-03AD-4755-B192-445C89E68005Q37704246-482B264B-6FD5-4099-96E5-9FAE3C8197B8Q37832786-67838F08-529B-4290-BE71-B94FEEE9132FQ37846879-879265ED-4012-4909-8D11-F99467C2B22DQ38769941-016D10C4-B6D5-49D4-95D2-17BAFDEBE657Q38955081-B0D863F7-9668-402A-9AD2-EBE91487F5C5Q39079405-1AA2D049-6A7C-459A-A1D0-CDBDC531B37DQ41929699-F7650CAA-66FF-404C-A203-2FD4D6B124D7Q46237143-145111D6-1F40-4BD0-A5CD-B2650232C235Q50277220-CE16FB3E-C5E4-452C-8E11-6E963B3B08D2Q52375272-E8848657-996E-4FA3-B6FF-404BEDC40D9C
P2860
Flipping the paradigm on malaria transmission-blocking vaccines.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Flipping the paradigm on malaria transmission-blocking vaccines.
@ast
Flipping the paradigm on malaria transmission-blocking vaccines.
@en
Flipping the paradigm on malaria transmission-blocking vaccines.
@nl
type
label
Flipping the paradigm on malaria transmission-blocking vaccines.
@ast
Flipping the paradigm on malaria transmission-blocking vaccines.
@en
Flipping the paradigm on malaria transmission-blocking vaccines.
@nl
prefLabel
Flipping the paradigm on malaria transmission-blocking vaccines.
@ast
Flipping the paradigm on malaria transmission-blocking vaccines.
@en
Flipping the paradigm on malaria transmission-blocking vaccines.
@nl
P2860
P356
P1476
Flipping the paradigm on malaria transmission-blocking vaccines
@en
P2093
Marcelo Jacobs-Lorena
P2860
P304
P356
10.1016/J.PT.2008.05.002
P577
2008-07-01T00:00:00Z